This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Transcriptome sequencing and network pharmacology-based approach to reveal the effect and mechanism of Ji Chuan Jian against Parkinson’s disease
BMC Complementary Medicine and Therapies Open Access 03 June 2023
-
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
Nature Communications Open Access 09 November 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Lan, G. et al. Astrocytic VEGFA: An essential mediator in blood–brain-barrier disruption in Parkinson’s disease. Glia https://doi.org/10.1002/glia.24109 (2021)
Related articles
Sweeney, M. D. et al. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150 (2018)
Lange, C. et al. Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat. Rev. Neurol. 12, 439–454 (2016)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wood, H. VEGFA mediates blood–brain barrier disruption in Parkinson disease. Nat Rev Neurol 18, 1 (2022). https://doi.org/10.1038/s41582-021-00594-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-021-00594-6
This article is cited by
-
Transcriptome sequencing and network pharmacology-based approach to reveal the effect and mechanism of Ji Chuan Jian against Parkinson’s disease
BMC Complementary Medicine and Therapies (2023)
-
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
Nature Communications (2022)